JLL vs OLMA · P/E 23, rev $13.31B vs $824.6M cap
Jones Lang LaSalle Incorporated (JLL) versus Olema Pharmaceuticals Inc (OLMA) — a side-by-side from cached financials, not a winner call.
Jones Lang LaSalle Incorporated (JLL) is a real estate services company listed on US.
Olema Pharmaceuticals Inc (OLMA) is a biotechnology company listed on NASDAQ.
Latest reported JLL revenue for 2026-06-30 was $13.31B. Net income was $373.7M. JLL currently screens at market cap $12.12B and trailing P/E 23.0.
OLMA does not have a complete income-statement cache yet.
JLL currently screens at market cap $12.12B and trailing P/E 23.0. OLMA currently screens at market cap $824.6M.
Not investment advice. Open the JLL and OLMA stock pages for the full models.
Not investment advice.